Premium
O2‐11‐06: Understanding the Costs of Dementia Diagnosis and Care and the Financial Benefits Arising from Identifying Rapid Progressors
Author(s) -
Grootoonk Sylke,
Wolz Robin,
Hall John,
Hill Derek L.
Publication year - 2016
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2016.06.459
Subject(s) - dementia , activity based costing , medicine , population , psychological intervention , disease , gerontology , intensive care medicine , business , psychiatry , accounting , environmental health
mated number of patients with AD older than 60 years of age in China in 2015 was 8.6 million, and its treatment rate was 30%. The annual costs were calculated and expressed in Chinese Renminbi (RMB). The yearly average monetary cost per person attributable to AD was 108,300RMB, in which the cost of per AD patient was 107,700RMB for outpatient treatment, 127,900RMB for hospitalized treatment and 75,400 RMB for without treatment, respectively. Considering the average annual ratio of inpatients and outpatients of different hospitals is about 1:6, the total monetary cost of AD in 2015 was RMB 739 billion. The expenditure will reach 951 billion RMB if all the patients accept a treatment. Moreover, the total number of people living with AD in 2020 was estimated at 11.0 million, which would reach 16.0 million by 2030. Conclusions:Chinese economic burden of AD is heavy, and will be heavier with the number of patients with AD increasing in the coming years. A national plan against dementia should be made for the policy makers.